Share this article Peter Thiel, the billionaire tech investor and co-founder of PayPal and Palantir, is part of an investor group that holds a 7.5% stake in 180 Life Sciences, which is rebranding as ETHZilla, an Ethereum-focused corporate treasury vehicle, according to a new SEC disclosure. Shares of 180 Life Sciences (ATNF) jumped over 11% at Monday’s close and surged roughly 57% in overnight trading, Yahoo Finance data shows. 180 Life Sciences announced its Ethereum treasury plan in late July. On Monday, the biotech firm said it sold $156 million in senior secured convertible notes due 2028 to an institutional investor, following a recent $425 million private placement. Proceeds will primarily fund Ethereum purchases, yield-bearing assets, and the company’s iGaming operations, while monetizing legacy biotech IP. Thiel’s investor group now has stakes in two Ethereum treasury companies. In mid-July, he reported holding over 9% of Tom Lee’s BitMine Immersion, currently the biggest corporate ETH holder with close to $5 billion in its treasury. Share this article
Top Altcoin Gainers: ETH, SOL, LINK, SUI & LTC Lead Market Rally
2 hour ago
Why is Dogecoin Price Up Today?
2 hour ago
Stripe Taps Paradigm’s Matt Huang to Lead New Blockchain Tempo: Fortune
2 hour ago
Why Is the Shiba Inu (SHIB) Price Up Today?
2 hour ago
Tezos to Feature Liquid Staking With stXTZ Launch on Etherlink
2 hour ago
Solana (SOL) Price Prediction for August 14
2 hour ago